P
Pierpaolo Di Micco
Researcher at Seconda Università degli Studi di Napoli
Publications - 126
Citations - 2057
Pierpaolo Di Micco is an academic researcher from Seconda Università degli Studi di Napoli. The author has contributed to research in topics: Pulmonary embolism & Thrombophilia. The author has an hindex of 22, co-authored 124 publications receiving 1594 citations. Previous affiliations of Pierpaolo Di Micco include University of Naples Federico II.
Papers
More filters
Journal ArticleDOI
Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Javier Trujillo-Santos,J.A. Nieto,G. Tiberio,Andrea Piccioli,Pierpaolo Di Micco,Paolo Prandoni,Manuel Monreal +6 more
TL;DR: This registry of consecutive patients with acute VTE tried to identify which cancer patients are at a higher risk for recurrent pulmonary embolism (PE), deep vein thrombosis (DVT) or major bleeding.
Journal ArticleDOI
Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry
TL;DR: Clinical factors predicting a fatal PE identified in this study, including cancer, immobility, comorbidities, increasing age, PE at presentation, could be considered for risk stratification scheme for secondary prophylaxis in daily practice.
Journal ArticleDOI
Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study.
Vincenzo Russo,Marco Di Maio,Emilio Attena,Angelo Silverio,Fernando Scudiero,Dario Celentani,Corrado Lodigiani,Pierpaolo Di Micco +7 more
TL;DR: Pre-admission antithrombotic therapy, both antiplatelet and anticoagulant, does not seem to show a protective effect in severe forms of COVID-19 with ARDS at presentation and rapidly evolving toward death.
Journal ArticleDOI
Venous thromboembolism during pregnancy, postpartum or during contraceptive use
Ángeles Blanco-Molina,Lidia Luciana Rota,Pierpaolo Di Micco,Benjamin Brenner,Javier Trujillo-Santos,Angeles Ruiz-Gamietea,Manuel Monreal +6 more
TL;DR: The outcome of pregnant or postpartum women with VTE is similar to that in contraceptive users, even though the treatment is different, and the non-specific nature of PE signs may have caused some delay in PE diagnosis.
Journal ArticleDOI
Clotting factors in COVID-19: Epidemiological association and prognostic values in different clinical presentations in an Italian cohort
Pierpaolo Di Micco,Vincenzo Russo,Novella Carannante,Michele Imparato,Stefano Rodolfi,Giuseppe Cardillo,Corrado Lodigiani +6 more
TL;DR: Fibrinogen seems to increase early in COVID-19 patients and may be used as a risk stratification marker for the early detection of a subgroup of CO VID-19 patient at increased risk to develop SARS, who might benefit from a different and thorough clinical surveillance and treatment.